ATXI Stock Predictions
| Recent ATXI Stock Price | ATXI Stock Predictions | |
| $4.15 |  +1255.42% |
$56.25 |
| Recent ATXI Analyst Ratings Breakdown, Making ATXI Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 1 | 1 | 1 | 1 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 0 | 0 | 0 | 0 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the ATXI stock predictions from the analysts covering Avenue Therapeutics Inc, we have collected all of the individual ATXI stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 1 different analysts covering ATXI (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since ATXI stock predictions may vary widely, another useful metric to consider is the median ATXI stock prediction, which represents the price at which half of the analysts
made ATXI stock predictions that were higher and half made ATXI stock predictions that were lower. This makes for a different take on the ATXI stock predictions out there, as compared to average or mean.
And that median across all the individual ATXI stock predictions was: $56.25 as of 2024-05-10.
The very highest of the ATXI stock predictions for one year price target was $56.25, while the very lowest of the ATXI stock predictions in the analyst group was
$56.25 (with a standard deviation of $0.0). Get the latest Zacks research report on ATXI — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• RCUS Stock Predictions
• RC Stock Predictions
• LSXMK Stock Predictions
• CMP Stock Predictions
• MHK Stock Predictions
• ARLP Stock Predictions
• DVAX Stock Predictions
• NRIX Stock Predictions
• NMRK Stock Predictions
|
|||||||||
|
|
|
|
|
|
Free Email Alerts:
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 98th percentile
(ranked higher than approx. 98% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
